Philip B. Heymann is James Barr Ames Professor of Law at Harvard Law School. William N. Brownsberger is a Massachusetts State Senator. Until 2007 he was Associate Director for Public Policy at the Division on Addictions, Cambridge Health Alliance, an affiliate of Harvard Medical School. Gene M. Heyman is a research psychologist at McLean Hospital and a Lecturer in Psychology at Harvard Medical School. Mark H. Moore is Hauser Professor of Nonprofit Organizations at the Harvard Kennedy School of Government and Herbert A. Simon Professor of Education, Management, and Organizational Behavior at the Harvard Graduate School of Education. He has also been a Visiting Professor of Business Administration at Harvard Business School. George E. Vaillant is Professor of Psychiatry at Harvard Medical School.

This book is first-rate. The command of the research literature is impressive and the wide range of contributors ensures that readers will be exposed to all aspects of the current questions concerning drug policy. From the wonderfully inclusive overview of Philip Heymann's introduction to the highly detailed discussion of data by William Brownsberger on drug users and drug dealers, each of the contributions is high quality and addresses a cutting edge issue.

• Introduction: Drug Policy with a New Focus Philip B. Heymann 1 Toward a Balanced Drug-Prevention Strategy: A Conceptual Map Mark H. Moore 2 Drug Users and Drug Dealers William N. Brownsberger 3 Is Addiction a Chronic, Relapsing Disease? Gene M. Heyman 4 Is Drug Addiction a Brain Disease? Sally L. Satel 5 If Addiction Is Involuntary, How Can Punishment Help? George E. Vaillant 6 Controlling Drug Use and Crime with Testing, Sanctions, and Treatment Mark A. R. Kleiman 7 Limits on the Role of Testing and Sanctions William N. Brownsberger 8 How Should Low-Level Drug Dealers Be Punished? Jonathan P. Caulkins and Philip B. Heymann 9 Reflections on Drug Policy and Social Policy David Boyum and Peter Reuter Postscript Philip B. Heymann Contributors

Philip B. Heymann is James Barr Ames Professor of Law at Harvard Law School. William N. Brownsberger is a Massachusetts State Senator. Until 2007 he was Associate Director for Public Policy at the Division on Addictions, Cambridge Health Alliance, an affiliate of Harvard Medical School. Gene M. Heyman is a research psychologist at McLean Hospital and a Lecturer in Psychology at Harvard Medical School. Mark H. Moore is Hauser Professor of Nonprofit Organizations at the Harvard Kennedy School of Government and Herbert A. Simon Professor of Education, Management, and Organizational Behavior at the Harvard Graduate School of Education. He has also been a Visiting Professor of Business Administration at Harvard Business School. George E. Vaillant is Professor of Psychiatry at Harvard Medical School.

This book is first-rate. The command of the research literature is impressive and the wide range of contributors ensures that readers will be exposed to all aspects of the current questions concerning drug policy. From the wonderfully inclusive overview of Philip Heymann's introduction to the highly detailed discussion of data by William Brownsberger on drug users and drug dealers, each of the contributions is high quality and addresses a cutting edge issue.

• Introduction: Drug Policy with a New Focus Philip B. Heymann 1 Toward a Balanced Drug-Prevention Strategy: A Conceptual Map Mark H. Moore 2 Drug Users and Drug Dealers William N. Brownsberger 3 Is Addiction a Chronic, Relapsing Disease? Gene M. Heyman 4 Is Drug Addiction a Brain Disease? Sally L. Satel 5 If Addiction Is Involuntary, How Can Punishment Help? George E. Vaillant 6 Controlling Drug Use and Crime with Testing, Sanctions, and Treatment Mark A. R. Kleiman 7 Limits on the Role of Testing and Sanctions William N. Brownsberger 8 How Should Low-Level Drug Dealers Be Punished? Jonathan P. Caulkins and Philip B. Heymann 9 Reflections on Drug Policy and Social Policy David Boyum and Peter Reuter Postscript Philip B. Heymann Contributors

Philip B. Heymann is James Barr Ames Professor of Law at Harvard Law School. William N. Brownsberger is a Massachusetts State Senator. Until 2007 he was Associate Director for Public Policy at the Division on Addictions, Cambridge Health Alliance, an affiliate of Harvard Medical School. Gene M. Heyman is a research psychologist at McLean Hospital and a Lecturer in Psychology at Harvard Medical School. Mark H. Moore is Hauser Professor of Nonprofit Organizations at the Harvard Kennedy School of Government and Herbert A. Simon Professor of Education, Management, and Organizational Behavior at the Harvard Graduate School of Education. He has also been a Visiting Professor of Business Administration at Harvard Business School. George E. Vaillant is Professor of Psychiatry at Harvard Medical School.

This book is first-rate. The command of the research literature is impressive and the wide range of contributors ensures that readers will be exposed to all aspects of the current questions concerning drug policy. From the wonderfully inclusive overview of Philip Heymann's introduction to the highly detailed discussion of data by William Brownsberger on drug users and drug dealers, each of the contributions is high quality and addresses a cutting edge issue.

• Introduction: Drug Policy with a New Focus Philip B. Heymann 1 Toward a Balanced Drug-Prevention Strategy: A Conceptual Map Mark H. Moore 2 Drug Users and Drug Dealers William N. Brownsberger 3 Is Addiction a Chronic, Relapsing Disease? Gene M. Heyman 4 Is Drug Addiction a Brain Disease? Sally L. Satel 5 If Addiction Is Involuntary, How Can Punishment Help? George E. Vaillant 6 Controlling Drug Use and Crime with Testing, Sanctions, and Treatment Mark A. R. Kleiman 7 Limits on the Role of Testing and Sanctions William N. Brownsberger 8 How Should Low-Level Drug Dealers Be Punished? Jonathan P. Caulkins and Philip B. Heymann 9 Reflections on Drug Policy and Social Policy David Boyum and Peter Reuter Postscript Philip B. Heymann Contributors